English
This article is from The Indian Journal of Medical Research , volume 137 . Abstract Background & objectives:: Galantamine, a centrally-acting cholinesterase inhibitor, has been used in the treatment of mild-to-moderate dementia of Alzheimer disease. Increased mortality, mainly due to cardiovascular events, was observed in placebo-controlled trials of galantamine. Several studies have evaluated the efficacy of galantamine in dementia, it is not clear whether it has an effect on platelet function. It is important to clarify this effect, because it may be related to thrombotic tendency or bleeding diathesis. This study was aimed to investigate the effect of galantamine on platelet aggregation in whole blood from healthy, elderly subjects. Methods:: Fifteen healthy (mean age 76.8 ± 7.2 yr) volunteers were included in the study. Three concentrations of galantamine solution (20, 40 and 80 ng/μl) were prepared. Each concentration of galantamine solution and control diluent without galantamine were incubated with whole blood. After incubation, aggregation responses were evaluated with ADP (5 μM) and collagen (2 μg/ml) in platelet-rich plasma. Results:: Compared to control, pre-incubation w
Sign in with your free account to read, download EPUBs or listen.
Ebook · Effect of galantamine on platelet functions in healthy elderly people. · Isik, Ahmet Turan, Bozoglu, Ergun, Kaptan, Kursat, Celik, Turgay · Internet Archive